UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2450-2456

2008

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1807-1813

2006

Link zum Volltext

Verfügbarkeit prüfen

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1728-1733

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9097-9104

2005

Link zum Volltext

Verfügbarkeit prüfen

Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma

Clinical lung cancer, 2013-07, Vol.14 (4), p.351-355

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

Clinical lung cancer, 2011, Vol.12 (1), p.33-37

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5242-5246

2006

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial

Clinical lung cancer, 2004-01, Vol.5 (4), p.231-236

2004

Link zum Volltext

Verfügbarkeit prüfen

Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxia

Seminars in oncology, 2002-02, Vol.29 (1), p.102-109

2002

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

Frontiers in oncology, 2013-01, Vol.3, p.219-219

2013

Link zum Volltext

Verfügbarkeit prüfen

Clonal Origin of Multiple Lung Cancers: K-ras and p53 Mutations Determined by Nonradioisotopic Single-strand Conformation Polymorphism Analysis

Diagnostic molecular pathology, 1997-08, Vol.6 (4), p.179-184

1997

Link zum Volltext

Verfügbarkeit prüfen

Bronchioloalveolar carcinoma: A model for investigating the biology of epidermal growth factor receptor inhibition

Clinical cancer research, 2004-06, Vol.10 (12), p.4205s-4209s

2004

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic thrombocytopenic purpura associated with quetiapine

The Annals of pharmacotherapy, 2005-07, Vol.39 (7-8), p.1346

2005

Link zum Volltext

Verfügbarkeit prüfen

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

Journal of thoracic oncology, 2006-07, Vol.1 (6), p.537-544

2006

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.126-134

2006

Link zum Volltext

Verfügbarkeit prüfen

Invited Commentary

The Annals of thoracic surgery, 2000-09, Vol.70 (3), p.937

Lau, Derick H.M

2000

Link zum Volltext

Verfügbarkeit prüfen

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: A California cancer consortium phase I and molecular correlative study

Clinical cancer research, 2003-10, Vol.9 (12), p.4356-4362

2003

Link zum Volltext

Verfügbarkeit prüfen

Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial

Anti-cancer drugs, 2005-03, Vol.16 (3), p.317-321

2005

Link zum Volltext

Verfügbarkeit prüfen

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

Journal of thoracic oncology, 2006-07, Vol.1 (6), p.537-544

2006

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.126-134

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Gemcitabine and Paclitaxel in Advanced Solid Tumors

Cancer investigation, 2003, Vol.21 (1), p.7-13

2003

Link zum Volltext

Verfügbarkeit prüfen

Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non[ndash ]small cell lung cancer: Focus on docetaxel

Seminars in oncology, 2001-06, Vol.28 (3 Suppl 9), p.26-32, Article asonc0280026f

2001

Link zum Volltext

Verfügbarkeit prüfen

O-187 ZD1839 (iressa) in advanced bronchioloalveolar carcinoma (BAC): A preliminary report of SWOG SO126

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S56-S56

2003

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial

Clinical lung cancer, 2004-09, Vol.6 (2), p.102-107

2004

Link zum Volltext

Verfügbarkeit prüfen

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5181-5187

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Oncology
(29)
Female
(24)
Male
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Middle Aged
(18)
Aged
(16)
Lung Neoplasms - Drug Therapy
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Pharmacology. Drug Treatments
(12)
Adult
(11)
Antineoplastic Agents
(11)
Aged, 80 And Over
(10)
Drug Administration Schedule
(10)
Chemotherapy
(9)
Lung Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial

Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxia

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

Clonal Origin of Multiple Lung Cancers: K-ras and p53 Mutations Determined by Nonradioisotopic Single-strand Conformation Polymorphism Analysis

Bronchioloalveolar carcinoma: A model for investigating the biology of epidermal growth factor receptor inhibition

Thrombotic thrombocytopenic purpura associated with quetiapine

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Invited Commentary

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: A California cancer consortium phase I and molecular correlative study

Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Phase I Trial of Gemcitabine and Paclitaxel in Advanced Solid Tumors

Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non[ndash ]small cell lung cancer: Focus on docetaxel

O-187 ZD1839 (iressa) in advanced bronchioloalveolar carcinoma (BAC): A preliminary report of SWOG SO126

Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin

Suchergebnisse filtern